Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseEarly Phase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismAngiogenesis inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AngioGenex, Inc.
0 Patents (Medical) associated with AngioGenex, Inc.
100 Deals associated with AngioGenex, Inc.
100 Translational Medicine associated with AngioGenex, Inc.